About Lumeda
Lumeda is a Healthcare company based in Rocky Hill (United States) founded in 2020 by Paul E Sanders and Trevor MacDougall. Photodynamic therapy device for lung cancer treatment is developed. Lumeda has raised $5.34 million across 2 funding rounds from investors including Connecticut Innovations and Cycle Capital. The company has 10 employees. Its chief executive, as recorded, is Alexander Zinke. Lumeda offers products and services including DigiLum™. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its legal entity is Lumeda Inc. Its competitors include Pulmonx, PhotoPharmics and Spiration; 3 of its 3 listed competitors have raised funding.
Company details
Lumeda was founded in 2020 and is based in Rocky Hill, United States. A photodynamic therapy device is developed by the company for lung cancer treatment within the medical device sector. Optical technology is utilized, along with photonics instrumentation and proprietary software, to automate light delivery to tumors and manage dosimetry profiles. Operations focus on advancing targeted oncology solutions through automated PDT applications.
- Headquarters Rocky Hill, United States
- Employees 10
- Founders Paul E Sanders, Trevor MacDougall
- SectorsHealthcare
- Website lumedainc.com
- Social LinkedIn
- Legal Name Lumeda Inc
- Total Equity Funding$5.34M (USD)
in 2 rounds
- Latest Funding Round$4.3M (USD), Series A
Feb 2021
- InvestorsConnecticut Innovations
& 1 more
- Employee Count10
Products & Services of Lumeda
Lumeda offers a comprehensive portfolio of products and services, including DigiLum™.
System for precise light dosing in treating solid tumors like lung cancer.
Funding Insights of Lumeda
Lumeda has successfully raised a total of $5.34M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.3 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $5.34M
- Total Rounds 2
- Last Round Series A — $4.3M
- First Round $1.04M
(Jun 2020)
- Investors Count 2
All 2 funding rounds of Lumeda with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $4.3M | Series A | – | Connecticut Innovations | |
| Jun 2020 | $1.04M | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in Lumeda
Lumeda has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Connecticut Innovations and Cycle Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital services for biotech, IT, and innovative sectors in Connecticut. | ctinnovations.com | |||
Cycle Capital is engaged in venture capital for clean tech innovations. | cyclecapital.com | Montreal, Canada |
Investor details for Lumeda
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lumeda
11 people are tracked at Lumeda (3 in leadership, 6 in board & advisors, 2 in team); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
Paul E Sanders | Co-Founder | Leadership |
Trevor MacDougall | Co-Founder | Leadership |
Alexander Zinke | CEO | Leadership |
Justin D. Blasberg | Scientific Advisor | Board & advisors |
Michael M. Conway | Scientific Advisor | Board & advisors |
Gal Shafirstein | Scientific Advisor | Board & advisors |
Sandra Gollnick | Scientific Advisor | Board & advisors |
Ron Weitzman | Scientific Advisor | Board & advisors |
Arthur DeCillis | Senior Clinical Advisor | Board & advisors |
Krenar Tasimi | Senior Electrical Engineer | Team |
Marc LaPierre | Senior Quality Manager | Team |
Complete people profiles for Lumeda
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lumeda
3 dated milestones of Lumeda across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Lumeda is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Series A, of $4.3M.
Competitors of Lumeda
Lumeda has 3 listed competitors in our database, 3 of them funded. They include Pulmonx, PhotoPharmics and Spiration.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pulmonx.com | 1998 | Redwood, United States | $280.91M | 198 | Developer of smart devices for treating pulmonary diseases | |
| photopharmics.com | 2011 | American Fork, United States | $43.44M | Non-invasive phototherapy for Parkinson's disease is developed. | ||
| spiration.com | 1999 | Redmond, United States | $73.9M | 74 | IntraBronchial Valve to treat lung disease |
Detailed competitors of Lumeda
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Lumeda (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lumeda
Complete news archive for Lumeda
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lumeda
Lumeda was founded in 2020.
Lumeda is headquartered in Rocky Hill, United States. It is registered at Rocky Hill, Connecticut, United States.
Alexander Zinke is the CEO of Lumeda, as recorded in our data.
Lumeda is a funded company, having raised a total of $5.34M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.04M, raised on Jun 2020.
Lumeda has 10 employees.
Lumeda was founded in 2020 and is based in Rocky Hill, United States. A photodynamic therapy device is developed by the company for lung cancer treatment within the medical device sector. Optical technology is utilized, along with photonics instrumentation and proprietary software, to automate light delivery to tumors and manage dosimetry profiles. Operations focus on advancing targeted oncology solutions through automated PDT applications.
Lumeda's top competitors include Pulmonx, PhotoPharmics and Spiration.
Lumeda offers DigiLum™.
Lumeda has 2 investors. Key investors include Connecticut Innovations, and Cycle Capital.
Lumeda operates through Lumeda Inc.